$6.84
10.35% day before yesterday
Nasdaq, Dec 27, 10:12 pm CET
ISIN
CA60255C1095
Symbol
MNMD
Sector
Industry

Mind Medicine Inc - Ordinary Shares (Sub Voting) Stock price

$6.84
-1.42 17.19% 1M
-0.41 5.66% 6M
+3.18 86.89% YTD
+3.05 80.47% 1Y
-17.76 72.20% 3Y
+6.83 56,900.00% 5Y
-20.10 74.61% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.79 10.35%
ISIN
CA60255C1095
Symbol
MNMD
Sector
Industry

Key metrics

Market capitalization $192.63m
Enterprise Value $-78.34m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 1.07
P/B ratio (TTM) P/B ratio 2.13
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-93.66m
Free Cash Flow (TTM) Free Cash Flow $-73.36m
Cash position $295.28m
EPS (TTM) EPS $-2.09
P/E forward negative
Short interest 13.25%
Show more

Is Mind Medicine Inc - Ordinary Shares (Sub Voting) a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Mind Medicine Inc - Ordinary Shares (Sub Voting) Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Mind Medicine Inc - Ordinary Shares (Sub Voting) forecast:

9x Buy
100%

Analyst Opinions

9 Analysts have issued a Mind Medicine Inc - Ordinary Shares (Sub Voting) forecast:

Buy
100%

Financial data from Mind Medicine Inc - Ordinary Shares (Sub Voting)

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
- -
-
100%
- Direct Costs 1.32 1.32
59% 59%
-
-1.32 -1.32
59% 59%
-
- Selling and Administrative Expenses 37 37
13% 13%
-
- Research and Development Expense 54 54
16% 16%
-
-92 -92
12% 12%
-
- Depreciation and Amortization 1.32 1.32
59% 59%
-
EBIT (Operating Income) EBIT -94 -94
9% 9%
-
Net Profit -98 -98
27% 27%
-

In millions USD.

Don't miss a Thing! We will send you all news about Mind Medicine Inc - Ordinary Shares (Sub Voting) directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Mind Medicine Inc - Ordinary Shares (Sub Voting) Stock News

Neutral
Business Wire
10 days ago
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will be added to the Nasdaq Biotechnology Index (NBI), effective at market open on Monday, December 23, 2024. “2024 has been a transformational year for MindMe...
Neutral
Business Wire
13 days ago
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that the first patient has been dosed in its Phase 3 Voyage study of MM120 ODT, a pharmaceutically optimized form of lysergide D-tartrate (LSD) for the treatment of GA...
Neutral
Business Wire
18 days ago
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it presented encore data from its Phase 2b study of MM120 (lysergide D-tartrate or LSD), the Company's lead product candidate in generalized anxiety disorder, at ...
More Mind Medicine Inc - Ordinary Shares (Sub Voting) News

Company Profile

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The firm develops a non-hallucinogenic version of the psychedelic ibogaine. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn in 2019 and is headquarter in New York, NY.

Head office Canada
CEO Robert Barrow
Employees 57
Founded 2019
Website www.mindmed.co

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today